ImageneBio, Inc.
IMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001835579
In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding ImageneBio, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 52 | 58 | +6 |
| Shares | 31.2M | 32.7M | +1.51M (+4.8%) |
| Value | $204.7M | $141.6M | −$63.1M (−30.8%) |
New holders (9)
Institutions that held ImageneBio, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 225,192 | $975.1K | 1.51% |
| NEA Management Company, LLC | 181,473 | $707.2K | 0.05% |
| Sofinnova Investments, Inc. | 115,712 | $501.0K | 0.03% |
| OUP Management Co., LLC | 26,833 | $116.2K | 0.26% |
| Two Sigma Investments, LP | 21,729 | $94.1K | 0.00% |
| Virtu Financial LLC | 11,675 | $51.0K | 0.01% |
| Voya Investment Management LLC | 11,176 | $48.4K | 0.00% |
| SG Americas Securities, LLC | 10,727 | $46.0K | 0.00% |
| Allspring Global Investments Holdings, LLC | 1,678 | $7.26K | 0.00% |
Sold out (3)
Institutions that held ImageneBio, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| MetLife Investment Management | 12,121 | $79.5K |
| Metropolitan Life Insurance Co | 1,256 | $8.24K |
| US Bancorp | 218 | $1.43K |